InfuSystem Stock Price, News & Analysis (NYSEAMERICAN:INFU)

$2.35 0.05 (2.17 %)
(As of 12/13/2017 08:04 AM ET)
Previous Close$2.30
Today's Range$2.29 - $2.35
52-Week Range$1.20 - $2.60
Volume28,500 shs
Average Volume31,732 shs
Market Capitalization$52.81 million
P/E RatioN/A
Dividend YieldN/A
Beta0.16

About InfuSystem (NYSEAMERICAN:INFU)

InfuSystem Holdings, Inc. is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states. It sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others.

Receive INFU News and Ratings via Email

Sign-up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorHealthcare
SymbolNYSEAMERICAN:INFU
CUSIPN/A
Phone+1-248-2911210

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($0.14)
Net IncomeN/A
Net Margins-0.73%
Return on Equity-1.06%
Return on Assets-0.59%

Miscellaneous

EmployeesN/A
Outstanding Shares22,780,000

InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions

What is InfuSystem's stock symbol?

InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

How were InfuSystem's earnings last quarter?

InfuSystem Holdings Inc (NYSEAMERICAN:INFU) announced its quarterly earnings data on Monday, December, 12th. The medical instruments supplier reported $0.00 earnings per share for the quarter. The medical instruments supplier earned $17.23 million during the quarter. InfuSystem had a negative return on equity of 1.06% and a negative net margin of 0.73%. View InfuSystem's Earnings History.

Who are some of InfuSystem's key competitors?

Who are InfuSystem's key executives?

InfuSystem's management team includes the folowing people:

  • Gregg O. Lehman Ph.D., Executive Chairman of the Board (Age 67)
  • Richard A. Diiorio, President, Chief Executive Officer, Director (Age 43)
  • Christopher Downs, Interim Chief Financial Officer, Executive Vice President (Age 59)
  • Janet Skonieczny, Chief Operating Officer, Executive Vice President, Compliance Officer and Privacy Officer (Age 56)
  • Trent N Smith, Executive Vice President, Chief Accounting Officer, Corporate Controller (Age 48)
  • Michael Milton McReynolds, Executive Vice President, Chief Information Officer (Age 46)
  • Darrell B. Montgomery, Director (Age 55)
  • Ryan J. Morris, Director (Age 32)
  • Christopher R. Sansone, Director
  • Scott A. Shuda, Director (Age 50)

How do I buy InfuSystem stock?

Shares of InfuSystem can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is InfuSystem's stock price today?

One share of InfuSystem stock can currently be purchased for approximately $2.35.

How big of a company is InfuSystem?

InfuSystem has a market capitalization of $52.81 million.

How can I contact InfuSystem?

InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.


MarketBeat Community Rating for InfuSystem (INFU)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  36 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  66
MarketBeat's community ratings are surveys of what our community members think about InfuSystem and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

InfuSystem (NYSEAMERICAN:INFU) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

InfuSystem (NYSEAMERICAN:INFU) Earnings History and Estimates Chart

Earnings by Quarter for InfuSystem (NYSEAMERICAN:INFU)

InfuSystem (NYSEAMERICAN INFU) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2017Q2 2017($0.02)$16.94 millionViewListenView Earnings Details
3/22/2017Q4 2016$0.07($0.01)$16.85 millionViewN/AView Earnings Details
12/12/2016Q3 2016$0.00$17.23 millionViewN/AView Earnings Details
8/10/2016Q216$0.04$17.20 million$19.10 millionViewListenView Earnings Details
5/10/2016Q116$0.02$16.70 million$19.00 millionViewN/AView Earnings Details
11/12/2015Q315$0.06$18.69 millionViewListenView Earnings Details
5/12/2015Q115$0.06$0.03$17.20 million$16.70 millionViewListenView Earnings Details
3/9/2015Q414$0.05$0.05$17.20 million$16.20 millionViewN/AView Earnings Details
11/10/2014Q3 2014$0.05$0.04$16.61 millionViewN/AView Earnings Details
8/1/2014Q2 2014$0.04$16.37 millionViewN/AView Earnings Details
5/5/2014Q1 2014$0.03$0.03$17.24 millionViewN/AView Earnings Details
3/11/2014$0.03$0.04ViewN/AView Earnings Details
11/12/2013Q3$0.02$0.03ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

InfuSystem (NYSEAMERICAN:INFU) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for InfuSystem (NYSEAMERICAN:INFU)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

InfuSystem (NYSEAMERICAN INFU) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for InfuSystem (NYSEAMERICAN:INFU)
Institutional Ownership by Quarter for InfuSystem (NYSEAMERICAN:INFU)

InfuSystem (NYSEAMERICAN INFU) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/8/2017Meridian Ohc Partners, LpDirectorBuy1,800$2.30$4,140.00View SEC Filing  
12/6/2017Meridian Ohc Partners, LpDirectorBuy7,300$2.30$16,790.00View SEC Filing  
11/27/2017Christopher R SansoneDirectorBuy2,000$2.20$4,400.00View SEC Filing  
11/21/2017Christopher R SansoneDirectorBuy54,344$2.09$113,578.96View SEC Filing  
9/11/2017Meridian Ohc Partners, LpDirectorBuy19,982$2.00$39,964.00View SEC Filing  
8/30/2017Meridian Ohc Partners, LpDirectorBuy30,900$1.90$58,710.00View SEC Filing  
8/28/2017Meridian Ohc Partners, LpDirectorBuy30,000$1.90$57,000.00View SEC Filing  
8/25/2017Meridian Ohc Partners, LpDirectorBuy13,381$1.84$24,621.04View SEC Filing  
8/24/2017Meridian Ohc Partners, LpDirectorBuy155$1.80$279.00View SEC Filing  
8/23/2017Meridian Ohc Partners, LpDirectorBuy2,166$1.80$3,898.80View SEC Filing  
8/16/2017Meridian Ohc Partners, LpDirectorBuy56,670$1.84$104,272.80View SEC Filing  
8/15/2017Richard DilorioDirectorBuy4,875$1.95$9,506.25View SEC Filing  
8/14/2017Christopher DownsCFOBuy7,900$1.90$15,010.00View SEC Filing  
8/14/2017Darrell B MontgomeryDirectorBuy25,000$1.88$47,000.00View SEC Filing  
6/7/2017Meridian Ohc Partners, LpDirectorBuy10,109$1.55$15,668.95View SEC Filing  
6/2/2017Meridian Ohc Partners, LpDirectorBuy10,100$1.55$15,655.00View SEC Filing  
5/25/2017Meridian Ohc Partners, LpDirectorBuy6,105$1.55$9,462.75View SEC Filing  
5/19/2017Ryan J MorrisDirectorBuy15,000$1.28$19,200.00View SEC Filing  
5/17/2017Ryan J MorrisDirectorBuy29,614$1.45$42,940.30View SEC Filing  
3/27/2017Ryan J MorrisDirectorBuy21,651$2.20$47,632.20View SEC Filing  
3/24/2017Ryan J MorrisDirectorBuy94,200$2.14$201,588.00View SEC Filing  
12/19/2016Eric K. SteenInsiderBuy12,000$2.33$27,960.00View SEC Filing  
12/16/2016Meridian Ohc Partners, LpDirectorBuy200,000$2.34$468,000.00View SEC Filing  
9/14/2016Ryan J MorrisDirectorBuy23,171$2.85$66,037.35View SEC Filing  
9/13/2016Ryan J MorrisDirectorBuy16,829$2.88$48,467.52View SEC Filing  
9/8/2016Ryan J MorrisDirectorBuy17,171$2.84$48,765.64View SEC Filing  
9/2/2016Ryan J MorrisDirectorBuy4,600$2.84$13,064.00View SEC Filing  
11/19/2015Eric K. SteenCEOBuy2,461$2.88$7,087.68View SEC Filing  
11/12/2015Meridian Ohc Partners, LpMajor ShareholderBuy29,600$2.82$83,472.00View SEC Filing  
11/3/2015Meridian Ohc Partners, LpMajor ShareholderBuy7,689$2.75$21,144.75View SEC Filing  
10/28/2015Meridian Ohc Partners, LpMajor ShareholderBuy17,100$2.71$46,341.00View SEC Filing  
10/13/2015Meridian Ohc Partners, LpMajor ShareholderBuy14,290$2.82$40,297.80View SEC Filing  
10/12/2015Meridian Ohc Partners, LpMajor ShareholderBuy1,860$2.83$5,263.80View SEC Filing  
8/24/2015Eric K. SteenCEOBuy5,000$2.83$14,150.00View SEC Filing  
8/19/2015Eric K. SteenCEOBuy7,360$2.92$21,491.20View SEC Filing  
8/18/2015Jonathan P FosterCFOBuy1,000$2.92$2,920.00View SEC Filing  
6/23/2015Meridian Ohc Partners, LpMajor ShareholderBuy7,500$3.19$23,925.00View SEC Filing  
6/15/2015Gregg Owen LehmanDirectorBuy2,000$3.23$6,460.00View SEC Filing  
6/12/2015Meridian Ohc Partners, LpMajor ShareholderBuy12,786$3.16$40,403.76View SEC Filing  
6/8/2015Gregg Owen LehmanDirectorBuy18,000$3.19$57,420.00View SEC Filing  
6/4/2015David C DreyerDirectorSell10,000$3.15$31,500.00View SEC Filing  
6/4/2015Meridian Ohc Partners, LpMajor ShareholderBuy19,550$3.15$61,582.50View SEC Filing  
5/19/2015Eric K SteenCEOBuy5,682$3.08$17,500.56View SEC Filing  
5/15/2015Jonathan P FosterCFOBuy4,270$3.07$13,108.90View SEC Filing  
12/16/2014Eric K SteenCEOBuy15,100$2.73$41,223.00View SEC Filing  
12/4/2014Eric K SteenCEOBuy3,669$2.65$9,722.85View SEC Filing  
11/26/2014Eric K SteenCEOBuy10,000$2.75$27,500.00View SEC Filing  
11/17/2014Eric K SteenCEOBuy10,000$2.69$26,900.00View SEC Filing  
8/27/2014Eric K SteenCEOBuy15,000$2.75$41,250.00View SEC Filing  
8/18/2014Eric K SteenCEOBuy12,750$2.79$35,572.50View SEC Filing  
8/13/2014Eric K SteenCEOBuy7,262$2.79$20,260.98View SEC Filing  
8/11/2014Eric K SteenCEOBuy11,172$2.71$30,276.12View SEC Filing  
5/7/2014Eric K SteenCEOBuy10,000$2.80$28,000.00View SEC Filing  
3/17/2014Ryan J MorrisChairmanSell24,600$2.90$71,340.00View SEC Filing  
3/13/2014Jonathan P FosterCFOBuy5,000$2.78$13,900.00View SEC Filing  
8/14/2013Eric K SteenCEOBuy15,000$1.42$21,300.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

InfuSystem (NYSEAMERICAN INFU) News Headlines

Source:

SEC Filings

InfuSystem (NYSEAMERICAN:INFU) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

InfuSystem (NYSEAMERICAN:INFU) Income Statement, Balance Sheet and Cash Flow Statement

Chart

InfuSystem (NYSEAMERICAN INFU) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.